#patritumab_deruxtecan
Patritumab deruxtecan
Antibody-drug conjugate
Patritumab deruxtecan is an experimental antibody–drug conjugate developed by Merck and Daiichi Sankyo to treat non-small-cell lung cancer.
Mon 15th
Provided by Wikipedia
This keyword could refer to multiple things. Here are some suggestions:
0 searches
This keyword has never been searched before
This keyword has never been searched for with any other keyword.